Helicobacter pylori infection: the latest in diagnosis and treatment
| dc.contributor.author | Abdur-Rahman, Fatima | |
| dc.contributor.author | Shaposhnikova, Yuliya | |
| dc.contributor.author | Zlatkina, Vira | |
| dc.date.accessioned | 2015-05-25T08:08:48Z | |
| dc.date.available | 2015-05-25T08:08:48Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Eradication rates may also be lower with 7 versus 14-day regimens. Bismuth-containing quadruple regimens for 7–14 days are another first-line treatment option. Sequential therapy for 10 days has shown promise in Europe but requires validation in North America. The most commonly used salvage regimen in patients with persistent H. pylori is bismuth quadruple therapy. Recent data suggest that a PPI, levofloxacin, and amoxicillin for 10 days is more effective and better tolerated than bismuth quadruple therapy for persistent H. pylori infection. | uk_UA |
| dc.identifier.citation | Abdur-Rahman F. Helicobacter pylori infection: the latest in diagnosis and treatment / F. Abdur-Rahman, Y. Shaposhnikova, V. Zlatkina // VІІІ Іnternational Scientific Іnderdisciplinary Сongrence for medical students and young scientists (ISIC), Kharkiv, 14th-15th of May 2015 : abstract book / ХНМУ. – Харьков, 2015. – С. 93. | uk_UA |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/9178 | |
| dc.language.iso | en | uk_UA |
| dc.subject | Helicobacter pylori | uk_UA |
| dc.subject | peptic ulcer | uk_UA |
| dc.subject | therapy | uk_UA |
| dc.title | Helicobacter pylori infection: the latest in diagnosis and treatment | uk_UA |
| dc.type | Thesis | uk_UA |